Publications by authors named "Laura Notarfranchi"

Claim this Profile
U
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.
Marta Lasa, Carmen Gonzalez, Laura Notarfranchi, Anastasiia Zherniakova, Diego Alignani

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.
Vincenzo Raimondi, Paola Storti, Rosanna Vescovini, Valentina Franceschi, Denise Toscani, Laura Notarfranchi

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.
Marta Lasa, Laura Notarfranchi, Cristina Agullo, Carmen Gonzalez, Sergio Castro

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 expression by plasma cells in extramedullary multiple myeloma.
Laura Notarfranchi, Fabrizio Accardi, Cristina Mancini, Eugenia Martella, Sabrina Bonomini

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of and as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Jessica Burroughs Garcia, Paola Storti, Nicolas Thomas Iannozzi, Valentina Marchica, Luca Agnelli, Laura Notarfranchi

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of CD56 expression in smoldering myeloma patients on early progression.
Laura Notarfranchi, Roberta Segreto, Rosanna Vescovini, Anna Benedetta Dalla Palma, Valentina Marchica

Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
Paola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Laura Notarfranchi

Oncoimmunology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.
Alessandra Romano, Paola Storti, Valentina Marchica, Grazia Scandura, Laura Notarfranchi

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
Laura Notarfranchi, Valentina Marchica, Benedetta Dalla Palma, Laura Pelagatti, Jessica Burroughs-Garcia

Acta Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
Federica Costa, Rosanna Vescovini, Valentina Marchica, Paola Storti, Laura Notarfranchi

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results.
Rita Fazzi, Iacopo Petrini, Nicola Giuliani, Riccardo Morganti, Giovanni Carulli, Laura Notarfranchi

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients.
Benedetta Dalla Palma, Fabrizio Accardi, Lucia Prezioso, Laura Notarfranchi, Nicola Giuliani

Leuk Lymphoma· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma.
Martina Manzoni, Valentina Marchica, Paola Storti, Bachisio Ziccheddu, Gabriella Sammarelli, Laura Notarfranchi

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma.
Simone Pacini, Marina Montali, Francesco Mazziotta, Claudia P Schifone, Lucia Macchia, Laura Notarfranchi

Oncotarget· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukaemia mimicking multiple myeloma.
Laura Notarfranchi, Filomena Russo, Francesca Re, Cristina Mancini, Eugenia Martella

Lancet Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.
Benedetta Dalla Palma, Valentina Marchica, Mario Pedrazzoni, Fabrizio Accardi, Laura Notarfranchi

Br J Haematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Fabrizio Accardi, Valentina Marchica, Cristina Mancini, Elena Maredi, Costantina Racano, Laura Notarfranchi

Hematol Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis.
Fabrizio Accardi, Valentina Papa, Anna Rita Capozzi, Gian Luca Capello, Laura Verga, Laura Notarfranchi

Case Rep Hematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties.
Federica Costa, Rosanna Vescovini, Marina Bolzoni, Valentina Marchica, Paola Storti, Laura Notarfranchi

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis